Intravaginal Mesalamine Administration: A Novel Technique for Neovaginal Colitis.

Creator(s)

Andrew M. Lupo
Ashli A. Lawson, Children's Mercy HospitalFollow
Rebecca M. Rentea, Children's Mercy HospitalFollow
Christina Low Kapalu, Children's Mercy Kansas City
John Rosen, Children's Mercy Kansas CityFollow

Document Type

Article

Publication Date

2-2024

Identifier

DOI: 10.1016/j.jpag.2023.08.006

Abstract

OBJECTIVE: We aim to present a novel technique for the treatment of neovaginal diversion colitis (also known as neovaginal colitis).

CASE: OT is a 21-year-old cisgender female with a history of VACTERL who underwent a colonic vaginoplasty as an infant. She presented with symptoms indicative of and later diagnosed as neovaginal diversion colitis. The patient underwent a novel regimen of vaginal instillation of mesalamine followed by complete resolution of her symptoms.

DISCUSSION: The following case study demonstrates a potentially effective treatment for cases of neovaginal diversion colitis.

Journal Title

Journal of pediatric and adolescent gynecology

Volume

37

Issue

1

First Page

93

Last Page

94

MeSH Keywords

Humans; Female; Young Adult; Adult; Mesalamine; Administration, Intravaginal; Vagina; Colitis; Plastic Surgery Procedures

Keywords

Colitis; Colonic vaginoplasty; Neovagina; Neovaginal colitis; Neovaginal diversion colitis; VACTERL; Vaginoplasty

Recommended Citation

Lupo AM, Lawson AA, Rentea RM, Kapalu CL, Rosen JM. Intravaginal Mesalamine Administration: A Novel Technique for Neovaginal Colitis. J Pediatr Adolesc Gynecol. 2024;37(1):93-94. doi:10.1016/j.jpag.2023.08.006